Hotline:
+ 49 (0) 2204 2918806

Market studies for category X

Items 1 to 10 of 543 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 55
  1. Net price*
    Year
  2. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Wockhardt Limited - Product Pipeline Review - 2013

    Global Markets Direct
    34 pages
    Global Markets Direct’s pharmaceuticals report, “Wockhardt Limited - Product Pipeline Review - 2013” provides data on the Wockhardt Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This repor
    Englisch | Zukunftsanalyse | SKU: 354963
  3. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Gene Signal International SA - Product Pipeline Review - 2013

    Global Markets Direct
    28 pages
    Global Markets Direct’s pharmaceuticals report, “Gene Signal International SA - Product Pipeline Review - 2013” provides data on the Gene Signal International SA’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorman
    Englisch | Zukunftsanalyse | SKU: 355027
  4. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    arGEN-X BV - Product Pipeline Review - 2013

    Global Markets Direct
    24 pages
    Global Market Direct’s pharmaceuticals report, “arGEN-X BV - Product Pipeline Review - 2013” provides data on the arGEN-X BV’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built usin
    Englisch | Zukunftsanalyse | SKU: 354738
  5. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Lycera Corp. - Product Pipeline Review - 2013

    Global Markets Direct
    22 pages
    Global Markets Direct’s pharmaceuticals report, “Lycera Corp. - Product Pipeline Review - 2013” provides data on the Lycera Corp.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built
    Englisch | Zukunftsanalyse | SKU: 355091
  6. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Myocardial Infarction - Pipeline Review, H2 2013

    Global Markets Direct
    258 pages
    Global Markets Direct’s, 'Myocardial Infarction - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Myocardial Infarction, complete with latest updates, and special features on late-stage and discontinued projects. It also revie
    Englisch | Zukunftsanalyse | SKU: 354803
  7. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Hemophilia - Pipeline Review, H2 2013

    Global Markets Direct
    220 pages
    Global Markets Direct’s, 'Hemophilia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hemophilia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involve
    Englisch | Zukunftsanalyse | SKU: 355155
  8. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Colon Cancer - Pipeline Review, H2 2013

    Global Markets Direct
    347 pages
    Global Markets Direct’s, 'Colon Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Colon Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players inv
    Englisch | Zukunftsanalyse | SKU: 354867
  9. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Contraception - Pipeline Review, H2 2013

    Global Markets Direct
    100 pages
    Global Markets Direct’s, 'Contraception - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Contraception, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players i
    Englisch | Zukunftsanalyse | SKU: 355219
  10. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Seek - Product Pipeline Review - 2013

    Global Markets Direct
    39 pages
    Global Markets Direct’s pharmaceuticals report, “Seek - Product Pipeline Review - 2013” provides data on the Seek’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and
    Englisch | Zukunftsanalyse | SKU: 354931
  11. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Virobay Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    26 pages
    Global Markets Direct’s pharmaceuticals report, “Virobay Inc. - Product Pipeline Review - 2013” provides data on the Virobay Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built
    Englisch | Zukunftsanalyse | SKU: 354995

Items 1 to 10 of 543 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 55